Skip to main content

Future Market Insights Analyzes Impact of COVID-19 on Generic Injectable Market; Stakeholders to Focus on Long-term Dimensions

Generic Injectable Sales Set to Grow Three-fold Between 2019 and 2029; ‘Biologics over Drugs’ Trend Assists Market Growth, Concludes Future Market Insights
Continued supply-demand imbalance in the drug sector is alarming, and pushing key manufacturers to emphasize expansion of manufacturing and distribution capabilities.
Currently at a nascent stage, the global generic injectable market is projected to witness exponential growth in sales at around 12% CAGR during 2019 – 2029. Over the course of forecast period, generic injectable sales will experience 3X growth, as indicated by a new Future Market Insights (FMI) study. Increasing patient preference for self-administration of drugs is primarily developing a fertile ground for the generic injectable market, says the report.
“The generic pharmaceuticals sector is gaining a boost from frequent FDA approvals. Launch of low-cost injectables through investments in consolidations and mergers has been a major highlight,” states the FMI report.
For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6051
Key Takeaways: Generic Injectable Market
  • Demand for monoclonal antibodies (mAbs) would remain significant; vaccines are gaining traction.
  • Generic injectable market continues to see emergence of high-value opportunities in North America and Europe.
  • Asian markets would capture investors’ attention, owing to solid growth in pharma production capacities and technology penetration.
  • High preference for small molecule drugs will prevail
  • Generic injectables continue to witness significant adoption in pain management.
  • Large molecule injectables are set to outperform their small counterparts by 2022.
Key Market Growth Drivers
  • Expansion of orphan drug and parenteral products spaces remains a strong factor driving generic injectable sales.
  • Increasing preference for cost-efficient biologics such as mAbs and vaccines over drugs is in favor of market growth.
  • Reduced development time and increasing manufacturers’ investments in consolidation are bolstering demand for generic injectables.
Key Restraints
  • Hefty operational costs will remain the key constraint facing generic injectable manufacturers.
  • Tightening competition from low-cost manufacturers continues to challenge large-scale players in generic injectable market.
Competition Analysis: Generic Injectable Market
This FMI study has covered some of the most prominent companies active in the generic injectable market, which include, but are not limited to, Pfizer Inc., Hospira Inc., Hikma, and Mylan. Key market players continue to maintain their strategic focus on expansion of business through mergers. Entering strategic distribution agreements will be a preferred move of market leaders in an effort to capture the untapped growth potential of generic injectable market.
Development of new development pipelines and extension of product portfolios continue to be the key strategies of players that look forward to unlock opportunities in the US generic injectable market. Increasing competition to penetrate developed regional markets is attracting investments towards introduction of patented complex biologics. Association with CMOs and CDMOs will be a profitable developmental strategy in terms of productivity and operational costs, says the report.
Request for Covid19 Impact Analysis: https://www.futuremarketinsights.com/covid19/rep-gb-6051
More About the Report
This Future Market Insights study of 239 pages offers actionable insights on the generic injectable market. The market analysis is based on product (monoclonal antibodies, immunoglobulin, cytokines, insulin, peptide hormones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, chemotherapy agents, and others), molecule type (small molecule and large molecule), application (oncology, infectious diseases, diabetes, blood disorders, hormonal disorders, musculoskeletal disorders, CNS diseases, pain management, and cardiovascular diseases), route of administration (IV, IM, and SC), and distribution channels (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies) across seven regions (Latin America, North America, Europe, South Asia, East Asia, Oceania, and MEA).

Comments

Post a Comment

Popular posts from this blog

Sales of Commercial Aircraft Video Surveillance Systems to Decelerate in 2020 as COVID 19 Pandemic Takes its Toll on Global Market

  Market Introduction Future Market Insights, in its recent study on the  Commercial Aircraft Video Surveillance Systems market,  offers a detailed value-volume analysis of the Commercial Aircraft Video Surveillance Systems market on the basis of various segments such as product type, application, aircraft type, assembly and region. In terms of product type, cabin surveillance systems is projected to be a lucrative segment in terms of growth opportunities and are mostly being installed in the line fit assembly applications in the commercial aircraft video surveillance systems. To Get the Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5202 There has been significant growth in the number of freighter planes due to expanding e-commerce and pharmaceutical sectors and outperforming global trade growth. From a macroeconomic point of view, demand for commercial aircrafts is anticipated to more than double in the next two decade...
1 comment
Read more

Automotive Battery Management System Market : Technological Growth Map over Time

  Automotive Battery Management System Market is estimated to reach US$ 15.3 Bn by the end of 2029 In the near future, electric vehicles will dominate the clean vehicle market, and necessitate demand for revolutionary battery management systems. Steadily growing demand for battery management systems in e-bikes as well as electric cars will squarely surge market growth. According to a new research report published by Future Market Insights (FMI), the  automotive battery management system market  is estimated to reach US$ 15.31 Bn by the end of 2029.  “In the foreseeable future, advancements in battery management systems will contribute towards extending vehicle range, while simultaneously improving battery life and safety. All major OEMs are ambitiously planning to boost electric vehicle production, which is projected to create significant opportunities for the global automotive battery management system market.” Key Takeaways of Automotive Battery Management Sys...
Post a Comment
Read more

Medical Gloves Market Trends, Growth, Future Demand, Analysis and Forecast by 2032

 The medical gloves market has witnessed significant growth and evolution, especially in recent years, due to the global healthcare challenges, including the COVID-19 pandemic. Medical gloves are crucial protective equipment used by healthcare professionals to prevent the transmission of infections, maintain hygiene standards, and ensure the safety of both patients and medical personnel. This market encompasses a wide range of glove types, including latex, nitrile, vinyl, and others, each with its unique features and applications. One of the key drivers of the medical gloves market is the increasing focus on infection prevention and control in healthcare settings. The heightened awareness of the importance of hand hygiene, especially in the wake of the pandemic, has led to a surge in demand for medical gloves worldwide. Healthcare facilities, including hospitals, clinics, and laboratories, require a steady and reliable supply of gloves to maintain safety protocols an...
Post a Comment
Read more